Published in

Elsevier, Journal of the Academy of Consultation-Liaison Psychiatry, 1(51), p. 62-67

DOI: 10.1016/s0033-3182(10)70660-5

Elsevier, Journal of the Academy of Consultation-Liaison Psychiatry, 1(51), p. 62-67

DOI: 10.1176/appi.psy.51.1.62

Links

Tools

Export citation

Search in Google Scholar

Novelty-Seeking in Parkinson's Disease After Deep Brain Stimulation of the Subthalamic Nucleus: A Case-Control Study

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Background: The prevalence of psychiatric comorbidity in Parkinson's disease (PD) is about 50%. Objective: The authors investigated differences among PD patients treated by deep brain stimulation (DBS), by drugs alone (noDBS), and healthy control subjects. Method: Samples of 22 subjects in each group were assessed with the Temperament and Character Inventory (TCI) and Hamilton scales for anxiety and depression (Ham-A and Ham-D). Results: Higher scores emerged on two Novelty-Seeking subscales in PD-DBS patients. Ham-A and Ham-D scores were lower in PD-DBS patients than in PD-noDBS patients and control subjects. Rigidity and non-impulsiveness were lower in PD-DBS than in PD-noDBS patients. Conclusion: Further studies should investigate whether or not these changes in personality are a consequence of the motor and depression improvement after DBS.